CAS No.: 216974-75-3
Bevacizumab/贝伐珠单抗 Catalog No. CSN_mab1012
Synonyms: Anti-Human VEGF, Humanized Antibody (PBS);Anti-Human VEGF;Humanized Antibody (PBS)
Bevacizumab is a recombinant humanized monoclonal immunoglobulin (Ig) G1 antibody that binds to all isoforms and bioactive proteolytic fragments of human vascular endothelial growth factor-A (VEGF), which is essential for both normal and tumor angiogenesis. It is approved for the treatment of patients with metastatic colorectal cancer, advanced nonsquamous non-small cell lung cancer, metastatic renal cell carcinoma, recurrent glioblastoma, advanced cervical cancer, and platinum-resistant ovarian cancer.
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
实验方案
- 计算器
技术信息
| CAS号 | 216974-75-3 | 储存条件 |
|
|
| 分子式 | 运输 | 蓝冰 | ||
| 分子量 | N/A | 别名 | Anti-Human VEGF, Humanized Antibody (PBS);Anti-Human VEGF;Humanized Antibody (PBS);贝伐珠单抗 (PBS);Anti-Human VEGF, Humanized Antibody (PBS |
